Trial intelligence / Profile preview

Use-results survey for E-fen buccal tablet in cancer breakthrough pain

jRCT1080222899

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Jun 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of fentanyl in breakthrough cancer pain (BTcP) and cancer pain, sponsored by Taiho Pharmaceutical Co., Ltd.

02

Drugs

fentanyl
03

Conditions

breakthrough cancer pain (BTcP)cancer pain

Beyond the preview

Go deeper on jRCT1080222899.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222899.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call